WHITE PETROLATUM and CELLULITIS

Overview

CELLULITIS is the #17 most commonly reported adverse reaction for WHITE PETROLATUM, manufactured by Aldermed Inc.. There are 40 FDA adverse event reports linking WHITE PETROLATUM to CELLULITIS. This represents approximately 1.5% of all 2,618 adverse event reports for this drug.

Patients taking WHITE PETROLATUM who experience cellulitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CELLULITIS is a less commonly reported adverse event for WHITE PETROLATUM, but still significant enough to appear in the safety profile.

Other Side Effects of WHITE PETROLATUM

In addition to cellulitis, the following adverse reactions have been reported for WHITE PETROLATUM:

• PYREXIA — 80 reports
• RASH — 77 reports
• DIARRHOEA — 73 reports
• NAUSEA — 72 reports
• PNEUMONIA — 66 reports
• DRUG INEFFECTIVE — 54 reports
• VOMITING — 52 reports
• DYSPNOEA — 51 reports
• OFF LABEL USE — 51 reports
• PRURITUS — 49 reports

Other Drugs Associated with CELLULITIS

The following drugs have also been linked to cellulitis in FDA adverse event reports:

Does WHITE PETROLATUM cause CELLULITIS?

CELLULITIS has been reported as an adverse event in 40 FDA reports for WHITE PETROLATUM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CELLULITIS with WHITE PETROLATUM?

CELLULITIS accounts for approximately 1.5% of all adverse event reports for WHITE PETROLATUM, making it a notable side effect.

What should I do if I experience CELLULITIS while taking WHITE PETROLATUM?

If you experience cellulitis while taking WHITE PETROLATUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages